TPG TPG revenue surges 27 percent yearoveryear to 322B in second quarter shares edge slightly higher Why Colony Bank CBAN financial health is stronger than most think Slight Uptick 20260508 Purple PPBT Annual Recap Q1 2025 Earnings Report Bond Market Headwinds Complicate Kevin Warshs Fed Balance Sheet Reduction Plan Cingulate CING Q1 2026 Results Miss Estimates EPS 095 vs 046 Berkshire Hathaway Reenters Airlines with 26 Billion Delta Air Lines Stake KimberlyClark Corporation KMB Q1 2026 Earnings Why the Beat Matters Pokmon Card Market Surges Amid Nostalgia Speculation and Celebrity Influence NVIDIA Reports First Quarter Fiscal 2027 Financial Results Inflation Reacceleration Spreads Beyond Oil and Iran These Sectors Are Seeing Price Hikes Tesla Surpasses Profit Expectations Despite Revenue Miss as Auto Margins Improve ProfitTaking Move Stock Surges 80 Since April Initiation Position Trimmed Disneys The Mandalorian and Grogu Opens to 82M Lowest in Star Wars Franchise History KKR Q1 2026 Earnings EPS Beats Estimates by 657 Stock Edges Lower VEON Q1 2026 Earnings EPS Beats Estimates Amid Operational Progress Odyssey Marine Exploration Inc OMEX Q1 2016 Earnings Surprise Profit as Revenue Remains Elusive Core Laboratories Q1 2026 Earnings EPS Misses Estimates as Market Challenges Persist VSCO Q1 2026 Earnings Earnings Beat Estimates Despite Limited Revenue Disclosure WEBTOON Entertainment WBTN Q1 2026 Earnings EPS Beat Driven by Cost Controls Amid Revenue Uncertainty InfuSystems Holdings Inc INFU Slips 282 as Selling Pressure Intensifies Support at 918 in Focus Elicio Therapeutics ELTX Bounces 45 as Biotech Sentiment Improves Where Food Comes From WFCF Slides 334 Key Support and Resistance Levels in Focus ACCESS Newswire Inc ACCS Seeks Support After Modest Decline A SPAC III Acquisition Corp ASPC Holds Steady at 1085 as Investors Await Business Combination Lithuania Data Breach Exposes 600000 National Records Raising Cybersecurity Concerns MFG Q1 2026 Earnings Strong Earnings Beat Driven by Core Business Momentum CytomX Therapeutics CTMX Holds Steady at 376 as Consolidation Continues